Global Osteoarthritis Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Osteoarthritis Treatment Market Research Report 2024
Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swelling, decreased range of motion, and, when the back is affected, weakness or numbness of the arms and legs. The most commonly involved joints are those near the ends of the fingers, at the base of the thumb, neck, lower back, knee, and hips. Joints on one side of the body are often more affected than those on the other. Usually the symptoms come on over years. It can affect work and normal daily activities. Unlike other types of arthritis, only the joints are typically affected.
According to MRAResearch’s new survey, global Osteoarthritis Treatment market is projected to reach US$ 6872.1 million in 2033, increasing from US$ 5454.1 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Osteoarthritis Treatment market research.
Owing to the growing lifestyle changes, increasing number of obesity cases, and an extensive rise in the geriatric population, cases of osteoarthritis are increasing in North America. As a result, the adoption of treatment and drugs is also increasing in the region. The availability of better treatment options, high awareness among the people, government reimbursement policies, and the willingness to take up treatment is expected to add up to the growth of the osteoarthritis treatment market in the region. In terms of the business opportunities, the U.S., Europe, and Asia Pacific are lucrative markets for osteoarthritis treatment and drugs due to high prevalence of the disease. Alternative and complementary medicines are of great interest to the patient population affected by osteoarthritis. In the U.S., alternative medicine segments are growing at a higher pace and have high potential for substantial research. Due to advancements in technology, osteoarthritis management becomes more focused towards effective treatment and this is expected to fuel the growth of the global osteoarthritis treatment market in the long run.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Osteoarthritis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer
Johnson & Johnson
Novartis
GlaxoSmithKline
Zimmer Biomet
Stryker
Abbott
Segment by Type
Drugs
Assistive Devices
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Osteoarthritis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Osteoarthritis Treatment market is projected to reach US$ 6872.1 million in 2033, increasing from US$ 5454.1 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Osteoarthritis Treatment market research.
Owing to the growing lifestyle changes, increasing number of obesity cases, and an extensive rise in the geriatric population, cases of osteoarthritis are increasing in North America. As a result, the adoption of treatment and drugs is also increasing in the region. The availability of better treatment options, high awareness among the people, government reimbursement policies, and the willingness to take up treatment is expected to add up to the growth of the osteoarthritis treatment market in the region. In terms of the business opportunities, the U.S., Europe, and Asia Pacific are lucrative markets for osteoarthritis treatment and drugs due to high prevalence of the disease. Alternative and complementary medicines are of great interest to the patient population affected by osteoarthritis. In the U.S., alternative medicine segments are growing at a higher pace and have high potential for substantial research. Due to advancements in technology, osteoarthritis management becomes more focused towards effective treatment and this is expected to fuel the growth of the global osteoarthritis treatment market in the long run.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Osteoarthritis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Johnson & Johnson
Novartis
GlaxoSmithKline
Zimmer Biomet
Stryker
Abbott
Segment by Type
Drugs
Assistive Devices
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Osteoarthritis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source